Table 1 Baseline characteristics of study participants in the intent-to-treat analysis (n = 718)
Total (n = 718) | AM (n = 360) | PZQ (n = 358) | |
|---|---|---|---|
Male gender | 399 (55.6) | 197 (54.7) | 202 (56.4) |
Female gender | 319 (44.4) | 163 (45.3) | 156 (43.6) |
Age (years), median (IQR) | 9.00 (7.00 to 11.0) | 9.00 (7.00 to 11.0) | 9.00 (7.00 to 11.0) |
Height (cm), median (IQR) | 132 (123 to 141) | 133 (123 to 142) | 131 (122 to 140) |
Weight (kg), median (IQR) | 25.0 (21.0 to 31.0) | 25.0 (21.0 to 31.0) | 25.0 (21.0 to 30.0) |
Schistosoma species | |||
Single S. haematobium infection | 609 (84.8) | 306 (85.0) | 303 (84.6) |
Single S. mansoni infection | 5 (0.70) | 5 (1.39) | 0 (0.00) |
Mixed infection | 104 (14.5) | 49 (13.6) | 55 (15.4) |
Schistosomiasis infection intensitya | |||
S. haematobium | |||
Light (<50 eggs per 10 ml urine) | 585 (81.5) | 294 (81.7) | 291 (81.3) |
Heavy (>50 eggs per 10 ml urine) | 128 (17.8) | 61 (16.9) | 67 (18.7) |
S. mansoni | |||
Light (1–99 eggs per gram stool) | 87 (12.1) | 44 (12.2) | 43 (12.0) |
Moderate (100–399 eggs per gram stool) | 19 (2.65) | 9 (2.50) | 10 (2.79) |
Heavy (>400 eggs per gram stool) | 3 (0.42) | 1 (0.28) | 2 (0.56) |
Clinical symptoms | |||
None | 615 (85.7) | 307 (85.28) | 308 (86.03) |
Abdominal pain | 16 (2.23) | 11 (3.06) | 5 (1.40) |
Blood in stool | 14 (1.95) | 7 (1.94) | 7 (1.96) |
Painful micturition | 8 (1.11) | 4 (1.11) | 4 (1.12) |
Gross hematuria | 65 (9.05) | 31 (8.61) | 34 (9.50) |
Indirect morbidity markers | |||
Presence of anemia (hemoglobin level <11.5 g dl−1) | 229 (31.9) | 112 (31.1) | 117 (32.7) |
Hemoglobin level (g dl−1), median (IQR) | 12.0 (11.3 to 12.7) | 12.0 (11.3 to 12.8) | 12.0 (11.3 to 12.7) |
Presence of fecal occult blood (positive or trace) | 166/682 (24.3) | 79/338 (23.4) | 87/344 (25.3) |
Presence of microhematuria (1+ to 4+ on urine dipstick) | 369/661 (55.8) | 183/339 (54.0) | 186/322 (57.8) |
Presence of proteinuria (1+ to 3+ on urine dipstick) | 294/661 (44.5) | 146/339 (43.1) | 148/322 (46.0) |
Abdominal ultrasound findings | |||
Uni- and/or bilateral ureteral abnormalities (partial dilatation) | 5/527 (1.0) | 2/267 (0.8) | 3/258 (1.2) |
Focal/multifocal bladder abnormalities (wall irregularities or thickness, or masses >10 mm) | 24/537 (4.5) | 7/274 (2.6) | 17/259 (6.6) |
Liver abnormal patterns (C to F)b | 9/531 (1.7) | 4/271 (1.5) | 5/260 (1.9) |